Stephen Hunger Research Program

Ongoing Research

Identifying the underlying genetic causes of high-risk acute lymphocytic leukemia can provide clues to potential therapeutic targets.

Ongoing clinical trials are improving survival for pediatric acute lymphocytic leukemia.

Treating patients with Philadelphia chromosome-like acute lymphoblastic leukemia with a combination of chemotherapy and tyrosine kinase inhibitors may result in higher cure rates.